Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis.
about
Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence.Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.Response to: Comment on "Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis".CCR9 AND CCR7 are overexpressed in CD4- CD8- thymocytes of myasthenia gravis patients.
P2860
Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Expression of immune molecules ...... severity of myasthenia gravis.
@en
Expression of immune molecules ...... severity of myasthenia gravis.
@nl
type
label
Expression of immune molecules ...... severity of myasthenia gravis.
@en
Expression of immune molecules ...... severity of myasthenia gravis.
@nl
prefLabel
Expression of immune molecules ...... severity of myasthenia gravis.
@en
Expression of immune molecules ...... severity of myasthenia gravis.
@nl
P2093
P2860
P1476
Expression of immune molecules ...... severity of myasthenia gravis.
@en
P2093
Hongzeng Li
Xianni Wang
Yongan Zhou
P2860
P2888
P304
P356
10.1007/S12031-013-9976-9
P577
2013-02-10T00:00:00Z
P6179
1040330339